Breaking News Instant updates and real-time market news.

ACXM

Acxiom

$43.40

0.59 (1.38%)

16:06
08/09/18
08/09
16:06
08/09/18
16:06

Acxiom reports Q1 adjusted EPS 24c, consensus 18c

Reports Q1 revenue $227.0M, consensus $220.42M.

  • 09

    Aug

  • 06

    Nov

ACXM Acxiom
$43.40

0.59 (1.38%)

04/04/18
SPHN
04/04/18
NO CHANGE
Target $32
SPHN
Overweight
Acxiom overreaction to Facebook news a buying opportunity, says Stephens
Stephens analyst Brett Huff noted that Acxiom (ACXM) CEO Scott Howe published a blog post stating that he has seen "some signs" that Facebook (FB) is reconsidering its new policy on data imports in light of advertiser concerns. Huff, who thinks the blog post is a potential indication of the level of concern advertisers are having about Facebook's recent move, remains a buyer of Acxiom shares as he views the recent negative stock reaction to Facebook's news as overdone. He maintains his $32 price target and Overweight rating on Acxiom shares.
04/16/18
BMOC
04/16/18
NO CHANGE
Target $170
BMOC
Market Perform
Facebook price target lowered to $170 at BMO Capital
BMO Capital analyst Daniel Salmon lowered his price target on Facebook (FB) to $170 from $175 and kept his Market Perform, citing the company's March 28th decision to close its Partner Categories. Salmon says that while a material revenue for Facebook from the decision is not expected, there may be some "minor" usership decline in the short run on privacy concerns and some advertisers may experience ROI degradation, just as data use platforms undergo "proactive and regulated changes". As part of his broader research note, the analyst also lowers his price target on Alliance Data Systems (ADS) to $230 from $250 and on Acxiom Corp (ACXM) to $33 from $39 with maintained Market Perform and Outperform ratings respectively.
07/03/18
WELS
07/03/18
NO CHANGE
Target $41
WELS
Outperform
Acxiom price target raised to $41 from $33 at Wells Fargo
Wells Fargo analyst William Warmington raised his price target for Acxiom (ACXM) to $41 from $33 after the company announced the sale of its Acxiom Marketing Solutions business to Interpublic Group (IPG) for $2.3B cash. The analyst reiterates an Outperform rating on Acxiom's shares.
07/17/18
WELS
07/17/18
NO CHANGE
Target $50
WELS
Outperform
Acxiom price target raised to $50 from $41 at Wells Fargo
Wells Fargo analyst William Warmington, Jr. raised his price target for Acxiom to $50 from $41 to reflect a higher multiple for LiveRamp based on a high-growth ad-tech comp set, LiveRamp's attractiveness as a strategic asset, and increased confidence in his CY2019 and CY2020 estimates. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

TWTR

Twitter

$38.48

-0.8 (-2.04%)

06:01
04/26/19
04/26
06:01
04/26/19
06:01
Periodicals
Twitter CEO Dorsey called Rep. Omar over Trump's tweet, Washington Post says »

Twitter CEO Jack Dorsey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

CVEO

Civeo

$2.19

-0.07 (-3.10%)

06:01
04/26/19
04/26
06:01
04/26/19
06:01
Earnings
Civeo reports Q1 EPS (11c), consensus (9c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 16

    May

POR

Portland General Electric

$51.51

0.31 (0.61%)

06:00
04/26/19
04/26
06:00
04/26/19
06:00
Earnings
Breaking Earnings news story on Portland General Electric »

Portland General Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

POR

Portland General Electric

$51.51

0.31 (0.61%)

05:59
04/26/19
04/26
05:59
04/26/19
05:59
Earnings
Portland General Electric reports Q1 EPS 82c, consensus 78c »

Reports Q1 revenue $573M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

VCRA

Vocera

$31.31

0.36 (1.16%)

, JWN

Nordstrom

$41.05

-0.945 (-2.25%)

05:59
04/26/19
04/26
05:59
04/26/19
05:59
Hot Stocks
Vocera says Nordstrom outfitting employees with wearable badges »

Vocera Communications…

VCRA

Vocera

$31.31

0.36 (1.16%)

JWN

Nordstrom

$41.05

-0.945 (-2.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 28

    May

  • 05

    Jun

TSLA

Tesla

$247.51

-11.19 (-4.33%)

05:59
04/26/19
04/26
05:59
04/26/19
05:59
Periodicals
Citron's Andrew Left says no longer long or short Tesla, Reuters reports »

Andrew Left, the founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WY

Weyerhaeuser

$26.27

-0.07 (-0.27%)

05:55
04/26/19
04/26
05:55
04/26/19
05:55
Earnings
Weyerhaeuser reports Q1 EPS ex-items 11c, consensus 9c »

Reports Q revenue $1.64B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 17

    May

  • 04

    Jun

GKOS

Glaukos

$71.40

0.31 (0.44%)

05:46
04/26/19
04/26
05:46
04/26/19
05:46
Hot Stocks
Glaukos enters collaboration, distribution agreement with Santen »

Santen Pharmaceutical and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 05

    Jun

  • 13

    Nov

NITE

Nightstar Therapeutics

$25.61

0.08 (0.31%)

, BIIB

Biogen

$229.78

5.46 (2.43%)

05:43
04/26/19
04/26
05:43
04/26/19
05:43
Hot Stocks
Nightstar: ISS, Glass Lewis recommend holders vote 'FOR' deal with Biogen »

Nightstar Therapeutics…

NITE

Nightstar Therapeutics

$25.61

0.08 (0.31%)

BIIB

Biogen

$229.78

5.46 (2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 01

    May

  • 04

    May

  • 29

    May

SNY

Sanofi

$41.27

-0.2 (-0.48%)

05:41
04/26/19
04/26
05:41
04/26/19
05:41
Earnings
Sanofi backs FY19 business EPS growth of 3%-5% at CER »

Sanofi continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 31

    May

  • 26

    Jun

SNY

Sanofi

$41.27

-0.2 (-0.48%)

05:39
04/26/19
04/26
05:39
04/26/19
05:39
Earnings
Sanofi reports Q1 business EPS EUR 1.42 vs. EUR 1.28 »

Reports Q1 revenue EUR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 31

    May

  • 26

    Jun

AZN

AstraZeneca

$39.07

0.35 (0.90%)

05:36
04/26/19
04/26
05:36
04/26/19
05:36
Earnings
AstraZeneca backs FY19 core EPS view of $3.50-$3.70 »

Backs FY19 product sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    May

  • 07

    May

  • 31

    May

  • 20

    Jun

AZN

AstraZeneca

$39.07

0.35 (0.90%)

05:32
04/26/19
04/26
05:32
04/26/19
05:32
Earnings
AstraZeneca reports Q1 reported EPS 47c, consensus 42c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    May

  • 07

    May

  • 31

    May

  • 20

    Jun

PRO

Pros Holdings

$45.06

-0.25 (-0.55%)

05:29
04/26/19
04/26
05:29
04/26/19
05:29
Recommendations
Pros Holdings analyst commentary at JPMorgan »

Pros Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ILMN

Illumina

$318.91

4.47 (1.42%)

05:27
04/26/19
04/26
05:27
04/26/19
05:27
Recommendations
Illumina analyst commentary at Piper Jaffray »

Illumina earnings selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 31

    May

  • 06

    Aug

  • 03

    Sep

ALGT

Allegiant Travel

$139.70

6.33 (4.75%)

05:22
04/26/19
04/26
05:22
04/26/19
05:22
Recommendations
Allegiant Travel analyst commentary at Imperial Capital »

Allegiant Travel price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

NFLX

Netflix

$368.20

-5.99 (-1.60%)

05:19
04/26/19
04/26
05:19
04/26/19
05:19
Recommendations
Netflix analyst commentary at Imperial Capital »

Imperial trims Netflix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

05:16
04/26/19
04/26
05:16
04/26/19
05:16
Recommendations
Amazon.com analyst commentary at Piper Jaffray »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 22

    May

  • 03

    Jun

SBUX

Starbucks

$77.07

0.65 (0.85%)

05:11
04/26/19
04/26
05:11
04/26/19
05:11
Downgrade
Starbucks rating change at Wells Fargo »

Starbucks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

, ONCE

Spark Therapeutics

$111.40

0.73 (0.66%)

05:10
04/26/19
04/26
05:10
04/26/19
05:10
Hot Stocks
Roche, Spark Therapeutics withdraw, refile premerger notification »

Roche (RHHBY) and Spark…

RHHBY

Roche

$0.00

(0.00%)

ONCE

Spark Therapeutics

$111.40

0.73 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 03

    May

  • 04

    May

  • 28

    May

  • 31

    May

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

VCRA

Vocera

$31.31

0.36 (1.16%)

05:10
04/26/19
04/26
05:10
04/26/19
05:10
Recommendations
Vocera analyst commentary at Piper Jaffray »

Vocera positioned for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 28

    May

  • 05

    Jun

ESPR

Esperion

$43.02

1.14 (2.72%)

05:06
04/26/19
04/26
05:06
04/26/19
05:06
Upgrade
Esperion rating change at Goldman Sachs »

Esperion upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 07

    May

MDCO

The Medicines Co.

$29.84

0.37 (1.26%)

05:05
04/26/19
04/26
05:05
04/26/19
05:05
Upgrade
The Medicines Co. rating change at Goldman Sachs »

The Medicines Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 08

    May

RS

Reliance Steel

$91.29

2.46 (2.77%)

05:03
04/26/19
04/26
05:03
04/26/19
05:03
Downgrade
Reliance Steel rating change at Jefferies »

Reliance Steel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

TAL

TAL Education

05:02
04/26/19
04/26
05:02
04/26/19
05:02
Downgrade
TAL Education rating change  »

TAL Education downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.